CATX - Perspective Therapeutics, Inc.

4.51
-0.200   -4.435%

Share volume: 2,376,426
Last Updated: 04-23-2026
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies: -0.01%

PREVIOUS CLOSE
CHG
CHG%
$4.71
-0.20
-0.04%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
34%
Profitability 35%
Dept financing 25%
Liquidity 57%
Performance 30%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-0.88%
1 Month
5.13%
3 Months
74.13%
6 Months
50.84%
1 Year
85.60%
2 Year
166.86%
Key data
Stock price
$4.51
P/E Ratio 
N/A
DAY RANGE
$4.44 - $4.87
EPS 
-$1.40
52 WEEK RANGE
$1.96 - $6.16
52 WEEK CHANGE
$88.70
MARKET CAP 
0.000
YIELD 
N/A
SHARES OUTSTANDING 
113.933 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-14-2025
BETA 
0.75
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$1,431,886
AVERAGE 30 VOLUME 
$1,063,126
Company detail
CEO: Lori A. Woods
Region: US
Website: isoray.com
Employees: 70
IPO year: 2007
Issue type: Common Stock
Market: NYSE American
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

Isoray, Inc. develops, manufactures, and sells isotope-based medical products and devices. CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal, and colorectal cancers. It sells its products to facilities or physician practices that utilize various surgical facilities.

Recent news